Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1.The time to recover; defined as the first day; during the 28 days after enrollment; on which a patient met the criteria for category 1;2; 0r 3 WHO ordinal scale. <br/ >2.To determine the effect of the medication on Von Willebrand Factor; Angiotensin II; aldosterone and D-Dimer Levels.Timepoint: Baseline <br/ >Day 1 <br/ >Day 4 <br/ >Day 7	1.The time to recover; defined as the first day; during the 28 days after enrollment; on which a patient met the criteria for category 1;2; 0r 3 WHO ordinal scale. <br/ >2.To determine the effect of the medication on Von Willebrand Factor; Angiotensin II; aldosterone and D-Dimer Levels.Timepoint: Baseline <br/ >Day 1 <br/ >Day 4 <br/ >Day 7
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
March 26, 2021, 2:21 p.m.	oms	1.The time to recover; defined as the first day; during the 28 days after enrollment; on which a patient met the criteria for category 1;2; 0r 3 WHO ordinal scale. <br/ >2.To determine the effect of the medication on Von Willebrand Factor; Angiotensin II; aldosterone and D-Dimer Levels.Timepoint: Baseline <br/ >Day 1 <br/ >Day 4 <br/ >Day 7	1.The time to recover; defined as the first day; during the 28 days after enrollment; on which a patient met the criteria for category 1;2; 0r 3 WHO ordinal scale. <br/ >2.To determine the effect of the medication on Von Willebrand Factor; Angiotensin II; aldosterone and D-Dimer Levels.Timepoint: Baseline <br/ >Day 1 <br/ >Day 4 <br/ >Day 7